← back to search

Jane Houldsworth

Mount Sinai Health System · US
Area of research
Pathology and Forensic Medicine · Surgery
Research interest
Research interests include Lymphoma Diagnosis and Treatment, Testicular diseases and treatments, Renal and related cancers, and Multiple Myeloma Research and Treatments.
h-index
50
citations
8,238
works
212
NIH funding
primary concept
Medicine
email

Recent publications

Real-world deployment of a fine-tuned pathology foundation model for lung cancer biomarker detection
Nature Medicine 2025cited by 34position: middledoi
A clinical benchmark of public self-supervised pathology foundation models.
2025cited by 23position: contributordoi
Real-world deployment of a fine-tuned pathology foundation model for lung cancer biomarker detection.
2025cited by 16position: contributordoi
Clinicopathologic and Molecular Analysis of Colorectal Carcinomas With Spectrum of Neuroendocrine Carcinoma Components.
2025cited by 0position: contributordoi
Fibroepithelial Neoplasm with Hybrid Features of Benign Phyllodes Tumor, Juvenile Papillomatosis, and Juvenile Fibroadenoma: A Case Report.
2025cited by 0position: contributordoi
Multiple Myeloma Risk and Outcomes Are Associated with Pathogenic Germline Variants in DNA Repair Genes
Blood Cancer Discovery 2024cited by 19position: middledoi
Multiple Myeloma Risk and Outcomes Are Associated with Pathogenic Germline Variants in DNA Repair Genes.
2024cited by 18position: contributordoi
Host Nuclear Genome Copy Number Variations Identify High-Risk Anal Precancers in People Living With HIV.
2024cited by 1position: contributordoi
Twenty-Five Years of Germline Genetic Testing and What May Lie Ahead
The Journal of Molecular Diagnostics 2024cited by 0position: contributordoi
Supplementary Figure 4 from Multiple Myeloma Risk and Outcomes Are Associated with Pathogenic Germline Variants in DNA Repair Genes
2024cited by 0position: contributordoi
Supplementary Table 6 from Multiple Myeloma Risk and Outcomes Are Associated with Pathogenic Germline Variants in DNA Repair Genes
2024cited by 0position: contributordoi
Supplementary Table 8 from Multiple Myeloma Risk and Outcomes Are Associated with Pathogenic Germline Variants in DNA Repair Genes
2024cited by 0position: contributordoi
Supplementary Table 3 from Multiple Myeloma Risk and Outcomes Are Associated with Pathogenic Germline Variants in DNA Repair Genes
2024cited by 0position: contributordoi
Supplementary Table 10 from Multiple Myeloma Risk and Outcomes Are Associated with Pathogenic Germline Variants in DNA Repair Genes
2024cited by 0position: contributordoi
Data from Multiple Myeloma Risk and Outcomes Are Associated with Pathogenic Germline Variants in DNA Repair Genes
2024cited by 0position: contributordoi
Supplementary Figure 1 from Multiple Myeloma Risk and Outcomes Are Associated with Pathogenic Germline Variants in DNA Repair Genes
2024cited by 0position: contributordoi
Supplementary Table 1 from Multiple Myeloma Risk and Outcomes Are Associated with Pathogenic Germline Variants in DNA Repair Genes
2024cited by 0position: contributordoi
Supplementary Table 7 from Multiple Myeloma Risk and Outcomes Are Associated with Pathogenic Germline Variants in DNA Repair Genes
2024cited by 0position: contributordoi
Supplementary Table 5 from Multiple Myeloma Risk and Outcomes Are Associated with Pathogenic Germline Variants in DNA Repair Genes
2024cited by 0position: contributordoi
Supplementary Figure 3 from Multiple Myeloma Risk and Outcomes Are Associated with Pathogenic Germline Variants in DNA Repair Genes
2024cited by 0position: contributordoi
Supplementary Table 4 from Multiple Myeloma Risk and Outcomes Are Associated with Pathogenic Germline Variants in DNA Repair Genes
2024cited by 0position: contributordoi
Supplementary Table 9 from Multiple Myeloma Risk and Outcomes Are Associated with Pathogenic Germline Variants in DNA Repair Genes
2024cited by 0position: contributordoi
Supplementary Figure 2 from Multiple Myeloma Risk and Outcomes Are Associated with Pathogenic Germline Variants in DNA Repair Genes
2024cited by 0position: contributordoi
Supplementary Table 2 from Multiple Myeloma Risk and Outcomes Are Associated with Pathogenic Germline Variants in DNA Repair Genes
2024cited by 0position: contributordoi
Platinum Sensitivity in <i>IDH1/2</i> Mutated Intrahepatic Cholangiocarcinoma: Not All "BRCAness" Is Created Equal.
2023cited by 1position: contributordoi
Anti-invasive efficacy and survival benefit of the YAP-TEAD inhibitor verteporfin in preclinical glioblastoma models.
2022cited by 87position: contributordoi
Single-cell spatial analysis of tumor immune architecture in diffuse large B-cell lymphoma.
2022cited by 35position: contributordoi
Primary hemangioblastoma of the kidney with molecular analyses by next generation sequencing: a case report and review of the literature.
2022cited by 12position: contributordoi
Solitary Peutz-Jeghers Type Polyp of Jejunum with Gastric Fundic and Antral Gland Lining Mucosa: A Case Report and Review of Literature.
2022cited by 4position: contributordoi
Characteristics Associated With Disparities Among Older Adults in Coronavirus Disease 2019 Outcomes in an Academic Health Care System.
2022cited by 1position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

Emilia Mia Sordillo · University of Michigan4 papers (2020–2021) · 4 papers (2020–2025)Sacha Gnjatic · Precision Research (United States)3 papers (2020–2021)Benjamin S Glicksberg · University of Hong Kong3 papers (2020–2021)Mary Beth Beasley · Icahn School of Medicine at Mount Sinai3 papers (2020–2021)Carlos Cordon‐Cardo · Mount Sinai Health System2 papers (2020–2021) · 2 papers (2025–2025)Bridget K. Marcellino · Tisch Cancer Institute2 papers (2020–2020)Chad Vanderbilt · Molecular Oncology (United States)2 papers (2025–2025)John Mascarenhas · Incyte (United States)2 papers (2020–2020) · 2 papers (2021–2025)Thomas J. Fuchs · Klinikum im Friedrichshain2 papers (2025–2025)Erin Moshier · Mount Sinai Hospital2 papers (2020–2024)Maria E. Arcila · Molecular Oncology (United States)1 papers (2025–2025)Ruliang Xu · New York University1 papers (2019–2019)Nicole Pfarr · Technical University of Munich1 papers (2025–2025)Tarek H. Mouhieddine · Harvard University1 papers (2024–2024)Mark A. Valasek · Bryan College1 papers (2019–2019) · 1 papers (2025–2025)Shingo Kihira · University of California, Los Angeles1 papers (2021–2021)